Astera Labs (NASDAQ:ALAB) Stock Price Down 2.6% – Here’s Why

Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report)’s share price was down 2.6% on Friday. The stock traded as low as $209.49 and last traded at $221.83. 4,068,200 shares traded hands during trading, a decline of 21% from the average daily volume of 5,141,032 shares. The stock had previously closed at $227.79.

Astera Labs News Roundup

Here’s some of the latest news about ALAB:

  • Positive Sentiment: An analyst raised the company’s FY2026 EPS forecast, a potentially supportive signal for earnings expectations. FY2026 EPS Forecast for Astera Labs Boosted by Analyst
  • Neutral Sentiment: Astera Labs presented at the BMO Capital Technology and Innovation Leaders Conference; the available report is a transcript and does not identify a specific new catalyst. BMO Capital Conference Transcript
  • Negative Sentiment: Recent coverage describes a mixed trading picture: record Q3 growth is being offset by heavier selling pressure. It also flags competition from Marvell and Credo, which could challenge Astera Labs’ growth. Mixed Trading After Record Q3 Growth

Analyst Ratings Changes

ALAB has been the subject of a number of recent analyst reports. Roth Capital reaffirmed a “buy” rating and set a $450.00 price target on shares of Astera Labs in a report on Wednesday, August 5th. Royal Bank Of Canada reduced their price objective on Astera Labs from $500.00 to $400.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 4th. Weiss Ratings lowered Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a research note on Friday, October 23rd. UBS Group decreased their target price on Astera Labs from $300.00 to $290.00 and set a “neutral” rating on the stock in a report on Wednesday, November 4th. Finally, TD Cowen lowered their target price on Astera Labs from $300.00 to $225.00 and set a “hold” rating for the company in a research note on Wednesday, November 4th. Thirteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and a consensus target price of $320.85.

Get Our Latest Analysis on Astera Labs

Astera Labs Trading Down 2.6%

The firm has a fifty day simple moving average of $294.27 and a 200-day simple moving average of $257.09. The stock has a market cap of $38.77 billion, a price-to-earnings ratio of 88.38 and a beta of 3.85.

Astera Labs (NASDAQ:ALAB – Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.19 by $0.13. The company had revenue of $584.90 million during the quarter, compared to analysts’ expectations of $550.78 million. Astera Labs had a return on equity of 25.35% and a net margin of 29.64%. The business’s revenue for the quarter was up 153.6% on a year-over-year basis. During the same period last year, the firm earned $0.49 EPS. On average, equities analysts predict that Astera Labs, Inc. will post 2.99 earnings per share for the current fiscal year.

Insider Activity

In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of the company’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief operating officer directly owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of the company’s stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $211.41, for a total transaction of $1,901,421.54. Following the transaction, the director owned 1,987 shares in the company, valued at approximately $420,071.67. The trade was a 81.91% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 408,558 shares of company stock worth $126,050,884. Corporate insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Entropy Technologies LP boosted its holdings in Astera Labs by 174.5% during the third quarter. Entropy Technologies LP now owns 26,942 shares of the company’s stock worth $9,591,000 after buying an additional 17,128 shares during the last quarter. L2 Asset Management LLC grew its position in shares of Astera Labs by 5.4% during the 3rd quarter. L2 Asset Management LLC now owns 910 shares of the company’s stock worth $324,000 after buying an additional 47 shares during the period. FORA Capital LLC increased its stake in shares of Astera Labs by 181.6% in the 3rd quarter. FORA Capital LLC now owns 45,108 shares of the company’s stock valued at $16,051,000 after acquiring an additional 29,087 shares during the last quarter. Pathstone Holdings LLC increased its stake in shares of Astera Labs by 36.2% in the 3rd quarter. Pathstone Holdings LLC now owns 17,034 shares of the company’s stock valued at $6,064,000 after acquiring an additional 4,528 shares during the last quarter. Finally, Marshall Wace LLP increased its stake in shares of Astera Labs by 819.7% in the 3rd quarter. Marshall Wace LLP now owns 377,675 shares of the company’s stock valued at $134,441,000 after acquiring an additional 336,610 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Company Profile

(Get Free Report)

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Further Reading

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.